Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 947.40 INR
Change Today 0.00 / 0.00%
Volume 0.0
SUNP On Other Exchanges
Symbol
Exchange
Natl India
OTC US
As of 7:07 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

sun pharmaceutical indus (SUNP) Snapshot

Open
946.00
Previous Close
942.00
Day High
956.00
Day Low
938.25
52 Week High
04/7/15 - 1,201
52 Week Low
05/22/14 - 572.00
Market Cap
2.3T
Average Volume 10 Days
32.9M
EPS TTM
15.18
Shares Outstanding
2.4B
EX-Date
09/11/14
P/E TM
62.4x
Dividend
1.50
Dividend Yield
0.16%
Current Stock Chart for SUN PHARMACEUTICAL INDUS (SUNP)

Related News

No related news articles were found.

sun pharmaceutical indus (SUNP) Related Businessweek News

View More BusinessWeek News

sun pharmaceutical indus (SUNP) Details

Sun Pharmaceutical Industries Limited, a specialty pharmaceutical company, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, such as psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics, ophthalmology, diabetology, musculo-skeletal and pain, gynecology, and urology, as well as antiasthamatic and antiallergic. It also provides APIs comprising anticancers, peptides, sex hormones, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.

Founded in 1983

sun pharmaceutical indus (SUNP) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: 23.1M
Wholetime Director and Member of Shareholders...
Total Annual Compensation: 23.1M
Whole Time Director
Total Annual Compensation: 8.5M
Compensation as of Fiscal Year 2014.

sun pharmaceutical indus (SUNP) Key Developments

Dilip Shanghvi Not To Buy Stake In Sun Pharma

In response to the news item titled "Daichi Sankyo to exit Company & Promoter Dilip Sanghvi may buy partial stake for 22500 crs,", Sun Pharmaceutical Industries Limited (BSE:524715) clarified that Dilip Shanghvi neither purchased nor agreed to purchase any shares of Sun Pharmaceutical in the said transaction.

Daiichi Likely To Sell Stake in Sun Pharma

Dilip Shanghvi is likely to buy stake in Sun Pharmaceutical Industries Limited (BSE:524715) from Daiichi Sankyo Company, Limited (TSE:4568). Shanghvi may buy a partial stake (up to 5%) from Daiichi Sankyo, which holds 8.93% in Sun Pharma.

Sun Pharmaceutical Industries Ltd. and the Technion - Israel institute of technology Form Research Collaboration to Develop New Class of Oncology Drugs

Sun Pharmaceutical Industries Ltd. and the Technion - Israel institute of technology, announced that their respective subsidiaries have entered into an exclusive worldwide research and license agreement. This agreement aims at the development of a joint project, based on new findings by Professor Aaron Ciechanover, Dr. Gila Maor and Professor Ofer Binah, that can potentially lead to the development of novel anti-cancer drugs. The pre-clinical research was funded thus far by Dr. Alfred Mann.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SUNP:IN 947.40 INR +5.40

SUNP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cipla Ltd/India 637.65 INR -26.30
Dr Reddy's Laboratories Ltd 3,484 INR -44.65
Endo International PLC $93.27 USD -0.81
Hospira Inc $87.61 USD -0.05
Perrigo Co PLC $192.89 USD -8.74
View Industry Companies
 

Industry Analysis

SUNP

Industry Average

Valuation SUNP Industry Range
Price/Earnings 32.7x
Price/Sales 11.3x
Price/Book 8.8x
Price/Cash Flow 34.9x
TEV/Sales 12.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUN PHARMACEUTICAL INDUS, please visit www.sunpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.